the chronic inflammation. 1 Recent studies have demonstrated that microbiota plays an essential role in fine-tuning the immune response. 2, 3 S aureus became an important player in the type 2 biased immune responses in the airways. 4, 5 S aureus is a Gram-positive, commensal organism with pathogenic properties. Over 30 percent of the human population are carriers of S aureus, harboring the bacteria either transiently or persistently in their nasal cavities. 6 In the majority of human carriers, S aureus causes no detectable adverse effects.
However, in patients with chronic rhinosinusitis with nasal polyps (CRSwNP), nasal colonization with S aureus and sensitization to S aureus enterotoxins are linked to a type 2 inflammatory response and asthma comorbidity. 7 S aureus enterotoxin-specific immunoglobulin E was shown to be functional independent of the atopic status of patients. 8, 9 Importantly, S aureus enterotoxin sensitization is associated with allergic polysensitization in adolescents. 10 Immunoproteomic analyses of the nasal polyps have identified detectable amounts of more than 600 S aureus proteins including α-hemolysin, γ-hemolysin, panton-valentine leukocidin, S aureus toxins, and S aureus protease-like proteins (Spls). 4, 11 Furthermore, Spls were shown to induce a specific immunoglobulin E (IgE) response in asthmatic patients. 4 Moreover, S aureus contributes to the initiation of a type 2 immune response by fast induction of innate cytokines and chemokines from airway epithelial cells. In murine models of co-exposure to Spls and ovalbumin (OVA), SplD breaks immune tolerance to the inert OVA, inducing the production of OVA-specific IgE and strong airway inflammatory responses. 5 Recently, it has been stressed that IL-33 is a critical cytokine in allergic polysensitization and plays an essential role in an altered immune tolerance 12 via activation of dendritic cells 13 and the induction of a type 2 immune response.
14 S aureus induces an increase in IL-33 protein levels in S aureus-infected nasal polyp tissue. 15 It has been shown that mice treated with SplD could initiate an IL-33 mediated airway inflammation, 5 supporting the role of S aureus-secreted factors. This mechanism could substantially contribute to the development of a severe and difficult to control airway disease ( Figure 1 ).
In the current review, we position Spls among other allergens with protease activity and provide a critical overview of emerging roles of Spls in a type 2-biased immune response. Finally, we delineate the role of proteases in the activation of the IL-33 signaling pathway, which is upstream of a type 2 inflammatory response. We 
| E XOG ENOUS PROTE A S E S-S E A SONAL AND PERENNIAL ALLERG EN S

| Airborne house dust mite allergens activate the airway epithelium
There are 24 groups of house dust mite (HDM) allergens out of which one comprises cysteine proteases and three groups are serine proteases. These proteases present a high IgE binding frequency, up to 100% in HDM allergic patients, and are thus major allergens. 16 Der p 1 alone can decrease the epithelial barrier by disrupting tight junctions and increase specific IgE production due to its proteolytic activity, cleaving the low-affinity IgE receptor CD23, which leads to IgE upregulation, and the IL-2 receptor CD25 on T cells resulting in a shift toward Th2 cell activation. 17 Allergens with protease activity mediate their action through cleavage of a family of G protein-coupled receptors called protein- 
21-23
Furthermore, HDM as well as the cysteine proteases bromelain and papain induce uric acid release while A alternata, Artemisia vulgaris, and Betula pendula extracts do not. 24, 25 This release of uric acid can further skew the T cell response toward a Th2 bias. 23 The diminished response against heat-inactivated or protease inhibitor-treated HDM allergens suggests that the proteolytic function is necessary for their allergenicity. 24 The cysteine proteases of HDM seem to be more important for allergic sensitization than the serine proteases because the allergic response toward HDM extract with lower serine protease activity was more pronounced than in extracts with higher activity. 26 House dust mite induces an upregulation of IL-33, triggering innate lymphoid cells type 2 (ILC2) and eosinophil recruitment to the lungs through RAGE-dependent VCAM expression. 24 Der p 1 can cleave IL-33 and thereby increase its cytokine activity. 27 In addition to their own allergens, HDM extracts can also contain IgE reactive bacterial products of S aureus or E coli derived from their natural microbiome. 28 Whether these products are proteases still needs to be elicited and it can only be speculated Alternaria alternata extract induces allergic asthma via IL-33 activation, dependent on the serine proteases in the extract. 22, 33 This further leads to activation of ILC2s and IL-5 production which causes the maturation of eosinophils in the bone marrow in response to A alternata. 34 Next to the serine protease activity in the A alternata extract, an aspartic protease of A alternata activates PAR2 and triggers degranulation of eosinophils. 35 Contradicting data can be found concerning the importance of protease activity in asthma induction.
While heat-inactivated or protease inhibitor-treated A alternata extracts induce allergic asthma to the same extent as nondenatured extract in one study, 36 another study shows that the protease activity is necessary for the development of lung inflammation and PAR2 activation.
37
Aspergillus fumigatus has four different proteases, the metalloprotease Asp f 5, an aspartic protease Asp f 10, and two serine proteases Asp f 13 and Asp f 18. 31 Asp f 5 and Asp f 13 deletion mutants showed reduced inflammatory cell recruitment and IL-13 production compared to the wild type in a murine inhalation model; however, IgE levels and Th2 cytokine levels were comparable to the wild-type treated mice. 38 Asp f 13 disrupts the epithelial barrier and the extracellular matrix of airway smooth muscle cells, leading to airway hyperreactivity in mice. 39 Pen c 13, a serine protease from Penicillium citrinum, also increased epithelial permeability and allergic airway inflammation in mice.
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| Bacteria as a source of allergens with protease activity
The fungal allergens Cur l 1 from Curvularia lunata and Cla h 9 from
Cladosporium herbarum are subtilisin-like serine proteases. 42, 43 Subtilisin (also called Alcalase) is a serine protease from Bacillus spp acting as a bacterial allergen, as it can induce specific IgE and IgG4 formation, accumulation of eosinophils in the airway lumen and goblet cell hyperplasia in mice. The active subtilisin triggers an early release of amphiregulin, TSLP, IL-1α, and IL-33, while proteolytically inactive subtilisin cannot induce this response. 44 IL-33 is processed to a more bioactive cytokine by subtilisin. 27 In humans, subtilisin and savinase, another Bacillus spp protease, cause specific IgE formation. 45 These findings are of special interest, because detergents contain protein engineered mutants of subtilisin and other bacterial proteases that have an increased stability. Some of these bacterial proteases are also used by the food industry. 46 
| Staphylococcus aureus proteases in type 2 immune responses
Staphylococcus aureus possesses ten major secreted proteases including a serine protease (V8 protease), a metalloprotease (aureolysin), two cysteine proteases (staphopain A and staphopain B), and six serine protease-like proteins (SplA, SplB, SplC, SplD, SplE, and SplF). Spls are proteases encoded by the spl operon, located on the pathogenicity island vSab. 47 The S aureus V8 protease and staphopains were shown to alter airway epithelial barrier integrity, modulate cytokine synthesis, and activate nuclear factor kappalight-chain enhancer of activated B cells (NF-κB) in the airway epithelial cells, therefore predisposing to allergic sensitization. 48 Recently, it has been shown that the majority of nasal polyp tissue colonized with S aureus contained IgG binding to SplA, SplB, and It is important to mention that SplF shows 94.6% sequence homology with SplD. 54 In mice, SplF induces airway inflammation comparable to SplD. 5 These data suggest a novel potent group of bacterial allergens present in S aureus.
However, we have shown that SplD does not directly activate PAR2 and its downstream signaling in vitro, while in vivo PAR2 is increased in the SplD-exposed lungs. This indicates an indirect activation of PAR2. 5 Moreover, IL-33 is an important regulator in the SplD-induced PAR2 activation, since in mice treated with SplD and sST2, the levels of PAR2 in the lungs were significantly decreased. 5 These data support the notion that endogenous proteases facilitate innate immune response induced by allergens.
| The role of proteases in the activation of IL-33
Interleukin-33 is one of the major cytokines in the regulation of the innate and adaptive immunity in the allergic airways. 22 It is important to point out that several alternatively spliced variants of IL-33 were detected in asthmatic patients. 73 Among them, an IL-33 isoform lacking exons 3 and 4, that was shown to have a cytoplasmic localization in airway epithelial cells, could be actively secreted and activate mast cells and basophils. 73 In asthmatic patients, this isoform is strongly associated with type 2 biased airway inflammation. 73 In CRSwNP mucosa, S aureus induces epithelial cell-derived release of IL-33 and TSLP via cell wall compartment-induced TLR2 activation. 15 However, it has been shown that SplD does not activate TLR2 directly 5 suggesting that other recognition mechanisms are in place.
| Endogenous protease inhibitors in the airways
Natural protease inhibitors exist for serine, cysteine, metallo-, and aspartic proteases. 74 Cystatin A is a cysteine protease inhibitor, and in combination with the serine protease inhibitor Kazal-type 5 (SPINK5), it is involved in the regulation of the innate cytokine (IL-25, IL-33, and TSLP) response of A alternata extract or S aureus V8 protease, when exposed to human bronchial epithelial cells. In eosinophilic CRSwNP, the expression of cystatin A and SPINK5 is decreased compared to nasal tissue of noneosinophilic CRS. 75 These findings underline the importance of antiprotease activity in the nasal mucosa for the prevention of detrimental effects of exposure to environmental allergens with protease activity and provide a possible explanation for the reduced capacity of epithelium to counteract the protease activity in CRSwNP, resulting in a sustained chronic type 2 inflammation. The role of this antiprotease network still needs to be discovered in the regulation of Spls' activity in chronic airway inflammation.
α1-Antitrypsin (A1AT) inhibits trypsin, KLK7, KLK14, neutrophil elastase, proteinase 3, and matriptase. It is an acute-phase protein with a high abundance in serum. Apart from inhibiting neutrophil proteases, A1AT also inhibits the migration and activation of neutrophils, 76 next to preventing the proteolytic maturation of matrix metalloproteinase-9 (MMP-9) by serine proteases from German cockroach extract. 77 IL-6 and to a lesser extent LPS, tumor necrosis factor-α (TNF-α), and IL-1β stimulate A1AT secretion from monocytes. 78 Proteome analysis of nasal secretion from allergic rhinitis (AR) patients and healthy controls revealed 2.5-fold higher levels of A1AT in AR patients. 79 The mast cell chymase mMCP-1 can be inhibited by A1AT1, A1AT2, and A1AT4 in the serum. bronchial asthma, atopic asthma, and IgE levels. 84, 85 Furthermore, one polymorphism in the promoter region of CMA1 is associated with atopic eczema. 86 The variability in copy number of human α-tryptase can also have an impact on total and HDM-specific IgE levels in asthmatic patients. Patients carrying one copy of α-tryptase had lower IgE levels and worse lung function, but two copies correlated with higher total and HDM-specific IgE levels. 87 Interestingly, α-tryptase is suggested to be enzymatically inactive. 88 Hereditary loss of α1-antitrypsin/SERPINA1 results in early-onset chronic obstructive pulmonary disease and emphysema. 89 A downstream mutation in serine protease inhibitor A3
(SERPINA3) has been identified as a possible susceptibility locus for childhood asthma. 90 Interestingly, cystic fibrosis patients deficient of α1-antichymotrypsin/SERPINA3 have significantly milder symptoms of lung inflammation than non-α1-antichymotrypsin deficient patients.
91
Whether there is a possible link of serine protease inhibitor production with the susceptibility of chronic inflammatory airway disease development upon S aureus colonization still needs to be investigated.
| Interference with the ST2/IL-33 signaling axis for therapeutic purposes
Blocking of the IL-33 pathway by different pharmacological and genetic tools can be a promising and an efficient strategy to inhibit inflammatory changes induced by different groups of allergens. Indeed, the critical role of IL-33 in the initiation and modulation of allergic airway disease has been already proven (Table 2) 
| CON CLUD ING REMARK S AND FUTURE PER S PEC TIVE S
In this review article, we underlined that the IL-33/ST2 signaling axis is activated in response to the major inhaled allergens from fungi, mites, and bacteria and highlighted the role of protease/antiprotease network in balancing the activity of exogenous proteolytic enzymes. Therefore, both signaling pathways represent potential targets for the future therapeutic interventions to prevent severe chronic type 2 biased airway inflammation. Deeper understanding of the interaction of S aureus-secreted compounds and subsequent immune responses in the host might help to understand how colonization of S aureus or exposure due to inhaled S aureus compounds can bias toward type 2 immune response in asthma and CRSwNP.
Identification of these complex interactions between S aureus and the immune system may lead to the development of novel efficient therapeutics to prevent an exuberant activation of the immune system induced by pathogenic germs colonizing mucosal surfaces.
It is important to state that many questions remain regarding the predisposition to a conversion of commensal S aureus lifestyle into pathologic colonization. It remains to be analyzed whether S aureus proteins contribute to initiation and acute exacerbations of human asthma and CRSwNP in the same way as shown in mice.
Answers to these remaining questions will eventually provide us with the necessary insights on how to modulate either S aureus and its proteases or the host response in order to treat chronic type 2 diseases when other treatment strategies fail.
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